246 related articles for article (PubMed ID: 17030351)
1. COX-2 and survivin are overexpressed and positively correlated in endometrial carcinoma.
Erkanli S; Bolat F; Kayaselcuk F; Demirhan B; Kuscu E
Gynecol Oncol; 2007 Feb; 104(2):320-5. PubMed ID: 17030351
[TBL] [Abstract][Full Text] [Related]
2. [Expression of P53, P63, and C-erbB-2 in endometrioid adenocarcinoma and their clinicopathological significance].
Hu WF; Liu MQ; Zhao Q
Ai Zheng; 2004 Sep; 23(9):1021-5. PubMed ID: 15363194
[TBL] [Abstract][Full Text] [Related]
3. Expression of survivin, PTEN and p27 in normal, hyperplastic, and carcinomatous endometrium.
Erkanli S; Kayaselcuk F; Kuscu E; Bagis T; Bolat F; Haberal A; Demirhan B
Int J Gynecol Cancer; 2006; 16(3):1412-8. PubMed ID: 16803539
[TBL] [Abstract][Full Text] [Related]
4. Expression of cyclin D1 in normal, hyperplastic and neoplastic endometrium and its correlation with Ki-67 and clinicopathological variables.
Ozuysal S; Oztürk H; Bilgin T; Filiz G
Arch Gynecol Obstet; 2005 Feb; 271(2):123-6. PubMed ID: 14740230
[TBL] [Abstract][Full Text] [Related]
5. Cyclooxygenase-2 and p53 expressions in endometrial cancer.
Jeon YT; Kang S; Kang DH; Yoo KY; Park IA; Bang YJ; Kim JW; Park NH; Kang SB; Lee HP; Song YS
Cancer Epidemiol Biomarkers Prev; 2004 Sep; 13(9):1538-42. PubMed ID: 15342458
[TBL] [Abstract][Full Text] [Related]
6. Estrogen and progesterone receptors and cyclooxygenase-2 expression in endometrial cancer, endometrial hyperplasia, and normal endometrium.
Orejuela FJ; Ramondetta LM; Smith J; Brown J; Lemos LB; Li Y; Hollier LM
Gynecol Oncol; 2005 May; 97(2):483-8. PubMed ID: 15863148
[TBL] [Abstract][Full Text] [Related]
7. Postmenopausal status, hypertension and obesity as risk factors for malignant transformation in endometrial polyps.
Giordano G; Gnetti L; Merisio C; Melpignano M
Maturitas; 2007 Feb; 56(2):190-7. PubMed ID: 16963204
[TBL] [Abstract][Full Text] [Related]
8. Survivin expression in in situ and invasive breast cancer relates to COX-2 expression and DCIS recurrence.
Barnes N; Haywood P; Flint P; Knox WF; Bundred NJ
Br J Cancer; 2006 Jan; 94(2):253-8. PubMed ID: 16421596
[TBL] [Abstract][Full Text] [Related]
9. Markers of proliferative activity are predictors of patient outcome for low-grade endometrioid adenocarcinoma but not papillary serous carcinoma of endometrium.
Al Kushi A; Lim P; Aquino-Parsons C; Gilks CB
Mod Pathol; 2002 Apr; 15(4):365-71. PubMed ID: 11950909
[TBL] [Abstract][Full Text] [Related]
10. CD44 variant 6 in endometrioid carcinoma of the uterus: its expression in the adenocarcinoma component is an independent prognostic marker.
Hoshimoto K; Yamauchi N; Takazawa Y; Onda T; Taketani Y; Fukayama M
Pathol Res Pract; 2003; 199(2):71-7. PubMed ID: 12747468
[TBL] [Abstract][Full Text] [Related]
11. The prognostic significance of COX-2 and survivin expression in ovarian cancer.
Athanassiadou P; Grapsa D; Athanassiades P; Gonidi M; Athanassiadou AM; Tsipis A; Patsouris E
Pathol Res Pract; 2008; 204(4):241-9. PubMed ID: 18171606
[TBL] [Abstract][Full Text] [Related]
12. Indoleamine 2,3-dioxygenase is a novel prognostic indicator for endometrial cancer.
Ino K; Yoshida N; Kajiyama H; Shibata K; Yamamoto E; Kidokoro K; Takahashi N; Terauchi M; Nawa A; Nomura S; Nagasaka T; Takikawa O; Kikkawa F
Br J Cancer; 2006 Dec; 95(11):1555-61. PubMed ID: 17117179
[TBL] [Abstract][Full Text] [Related]
13. Cyclin D1 expression in endometrioid-type endometrial adenocarcinoma is correlated with histological grade and proliferative activity, but not with prognosis.
Nishimura Y; Watanabe J; Jobo T; Kato N; Fujisawa T; Kamata Y; Kuramoto H
Anticancer Res; 2004; 24(4):2185-91. PubMed ID: 15330159
[TBL] [Abstract][Full Text] [Related]
14. Cyclooxygenase-2 expression in endometrial carcinoma: correlation with clinicopathologic parameters and clinical outcome.
Ferrandina G; Legge F; Ranelletti FO; Zannoni GF; Maggiano N; Evangelisti A; Mancuso S; Scambia G; Lauriola L
Cancer; 2002 Aug; 95(4):801-7. PubMed ID: 12209724
[TBL] [Abstract][Full Text] [Related]
15. NF-κB and COX-2 expression in nonmalignant endometrial lesions and cancer.
Faloppa CC; Baiocchi G; Cunha IW; Fregnani JH; Osorio CA; Fukazawa EM; Kumagai LY; Badiglian-Filho L; Pinto GL; Soares FA
Am J Clin Pathol; 2014 Feb; 141(2):196-203. PubMed ID: 24436266
[TBL] [Abstract][Full Text] [Related]
16. BAG-1 expression in normal endometrium, endometrial hyperplasia and endometrial cancer.
Song JY; Kim JW; Lee JK; Lee NW; Yeom BW; Kim SH; Lee KW
Acta Obstet Gynecol Scand; 2008; 87(8):862-7. PubMed ID: 18704778
[TBL] [Abstract][Full Text] [Related]
17. Clinical value of immunohistochemically detected lymphovascular invasion in endometrioid endometrial cancer.
Alexander-Sefre F; Singh N; Ayhan A; Thomas JM; Jacobs IJ
Gynecol Oncol; 2004 Feb; 92(2):653-9. PubMed ID: 14766262
[TBL] [Abstract][Full Text] [Related]
18. Significance of matrix metalloproteinase-7 [correction of matrix metalloproteinase-2], -11 and tissue inhibitor of metalloproteinase-1 expression in normal, hyperplastic and neoplastic endometrium.
Obokata A; Watanabe J; Nishimura Y; Arai T; Kawaguchi M; Kuramoto H
Anticancer Res; 2007; 27(1A):95-105. PubMed ID: 17352221
[TBL] [Abstract][Full Text] [Related]
19. Microsatellite instability in endometrioid type endometrial adenocarcinoma is associated with poor prognostic indicators.
An HJ; Kim KI; Kim JY; Shim JY; Kang H; Kim TH; Kim JK; Jeong JK; Lee SY; Kim SJ
Am J Surg Pathol; 2007 Jun; 31(6):846-53. PubMed ID: 17527071
[TBL] [Abstract][Full Text] [Related]
20. Cyclooxygenase-2 (COX-2) expression in human endometrial carcinoma and precursor lesions and its possible use in cancer chemoprevention and therapy.
Nasir A; Boulware D; Kaiser HE; Lancaster JM; Coppola D; Smith PV; Hakam A; Siegel SE; Bodey B
In Vivo; 2007; 21(1):35-43. PubMed ID: 17354612
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
